CONCERT PHARMACEUTICALS INC (CNCE) Stock Analyst Ratings
NASDAQ:CNCE - Nasdaq - US2060221056 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to CNCE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.9. This target is 42.17% above the current price.
CNCE was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CNCE.
In the previous month the buy percentage consensus was at a similar level.
CNCE was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-01-20 | JonesTrading | Downgrade | Buy -> Hold |
| 2022-09-13 | Truist Securities | Maintains | Buy |
| 2022-08-25 | JonesTrading | Initiate | Buy |
| 2021-10-05 | Mizuho | Maintains | Buy |